Split History
ETFs Holding MNKD »    MNKD Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
MannKind is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Co.'s approved product, Afrezza (insulin human) Inhalation Powder, is a rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a portable inhaler. According to our MNKD split history records, MannKind has had 1 split.
MNKD split history picture
MannKind (MNKD) has 1 split in our MNKD split history database. The split for MNKD took place on March 03, 2017. This was a 1 for 5 reverse split, meaning for each 5 shares of MNKD owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 200 share position following the split.

When a company such as MannKind conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the MNKD split history from start to finish, an original position size of 1000 shares would have turned into 200 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into MannKind shares, starting with a $10,000 purchase of MNKD, presented on a split-history-adjusted basis factoring in the complete MNKD split history. MNKD split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 12/08/2009
End date: 12/06/2019
Start price/share: $38.25
End price/share: $1.21
Dividends collected/share: $0.00
Total return: -96.84%
Average Annual Total Return: -29.20%
Starting investment: $10,000.00
Ending investment: $316.47
Years: 10.00
Date Ratio
03/03/20171 for 5
MNKD is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

MOH Split History
MR Split History
MRK Split History
MSON Split History
MTEM Split History
MYG Split History
MYGN Split History
MYL Split History
NAVB Split History
NBS Split History

Also explore: MNKD shares outstanding history

iMedia Brands, Inc. (IMBI)
Akers Biosciences, Inc. (AKER)
NeuroMetrix, Inc. (NURO)
TRACON Pharmaceuticals (TCON)
SELLAS Life Sciences Group, Inc. (SLS)
Tonix Pharmaceuticals Holding Corp. (TNXP)
Camber Energy, Inc. (CEI)
Cancer Genetics, Inc. (CGIX)
Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3X Shares (GUSH)
Kingold Jewelry, Inc. (KGJI)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

MNKD Insider Buying

MNKD Split History | www.SplitHistory.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.